Galen, Peter
- Hemex Health, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,241
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
NIH Funding · FY2023
Linked Award Amount
$1.9M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#4,241
By linked amount among FY2023 PIs
Earliest Year Loaded
2017
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Galen, Peter as a PI. Multi-PI records show the full award amount for context.
- 2R44HL140739-04R44Contact PIAffordable, quantitative, point-of-care microchip-electrophoresis for screening and treatment monitoring of sickle cell disease, thalassemias, and anemias$1Maward amount
- 5R42DK119048-03R42Contact PIPortable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testing$865.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Galen, Peter as a PI.
FY2023 award administered by Hemex Health, Inc. (OR).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardHemex Health, Inc.
- 2017$500K Cumulative Funding
- 2018$1M Cumulative Funding
- 2018Entered Top 50% NationallyRanked #5951
- 2019$2M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #3055
- 2022$5M Cumulative Funding